720 related articles for article (PubMed ID: 18337437)
1. Evolving roles of oncology pharmacists in Singapore: a survey on prescribing patterns of antiemetics for chemotherapy induced nausea and vomiting (CINV) at a cancer centre.
Chan A; Shih V; Chew L
J Oncol Pharm Pract; 2008 Mar; 14(1):23-9. PubMed ID: 18337437
[TBL] [Abstract][Full Text] [Related]
2. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.
Shih V; Wan HS; Chan A
Ann Pharmacother; 2009 Mar; 43(3):444-52. PubMed ID: 19193584
[TBL] [Abstract][Full Text] [Related]
3. International patterns of practice in the management of radiation therapy-induced nausea and vomiting.
Dennis K; Zhang L; Lutz S; van Baardwijk A; van der Linden Y; Holt T; Arnalot PF; Lagrange JL; Maranzano E; Liu R; Wong KH; Wong LC; Vassiliou V; Corn BW; De Angelis C; Holden L; Wong CS; Chow E
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e49-60. PubMed ID: 22704982
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced nausea and vomiting in the treatment of gastrointestinal tumors and secondary prophylaxis with aprepitant.
Abbrederis K; Lorenzen S; Rothling N; Ihbe-Heffinger A; Schuster T; Peschel C; Lordick F
Onkologie; 2009 Feb; 32(1-2):30-4. PubMed ID: 19209016
[TBL] [Abstract][Full Text] [Related]
5. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics.
Grunberg SM; Deuson RR; Mavros P; Geling O; Hansen M; Cruciani G; Daniele B; De Pouvourville G; Rubenstein EB; Daugaard G
Cancer; 2004 May; 100(10):2261-8. PubMed ID: 15139073
[TBL] [Abstract][Full Text] [Related]
6. Oncologist perspectives on chemotherapy-induced nausea and vomiting (CINV) management and outcomes: A quantitative market research-based survey.
Aapro M; Ruffo P; Panteri R; Costa S; Piovesana V
Cancer Rep (Hoboken); 2018 Dec; 1(4):e1127. PubMed ID: 32729252
[TBL] [Abstract][Full Text] [Related]
7. [Perceptual gap between oncologists/oncology nurses and patients in the management and impact of chemotherapy/radiotherapy-induced nausea and vomiting: French results of the GAP survey].
Morin S; Leurs I; Bousquet MN; Scotté F
Bull Cancer; 2016 May; 103(5):469-77. PubMed ID: 27015797
[TBL] [Abstract][Full Text] [Related]
8. The compliance with antiemetic guidelines of Turkish medical oncologists. A survey study of Turkish Oncology Group.
Araz M; Karaagac M; Korkmaz L; Beypinar I; Uysal M
Curr Probl Cancer; 2019 Aug; 43(4):344-353. PubMed ID: 30497851
[TBL] [Abstract][Full Text] [Related]
9. A survey of antiemetic use in children with cancer.
van Hoff J; Hockenberry-Eaton MJ; Patterson K; Hutter JJ
Am J Dis Child; 1991 Jul; 145(7):773-8. PubMed ID: 2058609
[TBL] [Abstract][Full Text] [Related]
10. Acupressure for chemotherapy-induced nausea and vomiting: a randomized clinical trial.
Dibble SL; Luce J; Cooper BA; Israel J; Cohen M; Nussey B; Rugo H
Oncol Nurs Forum; 2007 Jul; 34(4):813-20. PubMed ID: 17723973
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of antiemetic practices for prevention of chemotherapy-induced nausea and vomiting (CINV): results of a European oncology nurse survey.
Dielenseger P; Börjeson S; Vidall C; Young A; Jahn P
Support Care Cancer; 2019 Nov; 27(11):4099-4106. PubMed ID: 30783815
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations.
Jordan K; Sippel C; Schmoll HJ
Oncologist; 2007 Sep; 12(9):1143-50. PubMed ID: 17914084
[TBL] [Abstract][Full Text] [Related]
13. Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting.
Oo TH; Hesketh PJ
Nat Clin Pract Oncol; 2005 Apr; 2(4):196-201. PubMed ID: 16264934
[TBL] [Abstract][Full Text] [Related]
14. Nausea and vomiting with high-dose chemotherapy and stem cell rescue therapy: a review of antiemetic regimens.
Trigg ME; Inverso DM
Bone Marrow Transplant; 2008 Oct; 42(8):501-6. PubMed ID: 18724391
[TBL] [Abstract][Full Text] [Related]
15. Pharmacist management of antiemetic therapy under protocol in an oncology clinic.
Martin JK; Norwood MB
Am J Hosp Pharm; 1988 Jun; 45(6):1322-8. PubMed ID: 3414699
[TBL] [Abstract][Full Text] [Related]
16. Acute and delayed nausea and emesis control in pediatric oncology patients.
Holdsworth MT; Raisch DW; Frost J
Cancer; 2006 Feb; 106(4):931-40. PubMed ID: 16404740
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and cost effectiveness of new antiemetic guidelines.
Engstrom C; Hernandez I; Haywood J; Lilenbaum R
Oncol Nurs Forum; 1999 Oct; 26(9):1453-8. PubMed ID: 11064877
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of aprepitant in management of chemotherapy-induced nausea and vomiting.
Osorio-Sanchez JA; Karapetis C; Koczwara B
Intern Med J; 2007 Apr; 37(4):247-50. PubMed ID: 17388865
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis of acute chemotherapy-induced nausea and vomiting in children with cancer: what is the evidence?
Antonarakis ES; Evans JL; Heard GF; Noonan LM; Pizer BL; Hain RD
Pediatr Blood Cancer; 2004 Nov; 43(6):651-8. PubMed ID: 15390297
[TBL] [Abstract][Full Text] [Related]
20. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A
J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
